Good
Mostly Aligned
Patient Risk:
Moderate
Summary
Most content-matching claims (composition, indication, dosing cadence, and several adverse effects) aligns with the provided label excerpts. However, two safety/triage statements about when to seek urgent medical care are not supported by the supplied prescribing information, and several minor labeling-specific phrases (e.g., “brand-name product” and exact meaning of “28”) are not explicitly stated.
Category Scores
Accurate Statements
Vienva 28 contains ethinyl estradiol and levonorgestrel.
INDICATIONS AND USAGE: “levonorgestrel and ethinyl estradiol tablets, USP”.
Vienva 28 is a combined hormonal contraceptive.
INDICATIONS AND USAGE (contraception); WARNINGS/other sections refer to CHCs/COCs containing levonorgestrel and ethinyl estradiol.
Vienva 28 is taken once daily following the schedule in the pack.
DOSAGE AND ADMINISTRATION: “must be taken exactly as directed and at intervals not exceeding 24 hours”; “one white tablet daily for 21 consecutive days, followed by one peach inert tablet daily for 7 consecutive days… at the same time each day.”
Common side effects of Vienva 28 can include nausea.
ADVERSE REACTIONS: “Common adverse reactions… include… nausea”.
Common side effects of Vienva 28 can include breast tenderness.
ADVERSE REACTIONS: includes “breast tenderness”.
Common side effects of Vienva 28 can include spotting or breakthrough bleeding, especially in the first few months.
WARNINGS: “Unscheduled bleeding and spotting… especially during the first three months of use”; DOSAGE AND ADMINISTRATION (continue regimen if spotting/breakthrough bleeding occurs).
Common side effects of Vienva 28 can include headache.
ADVERSE REACTIONS: “Common adverse reactions… include… headache”.
Common side effects of Vienva 28 can include mood changes.
ADVERSE REACTIONS: “Psychiatric disorders: … mood changes”.
Unsupported Statements
The “28” in Vienva 28 refers to a 28-day pill pack.
The provided excerpts describe a 21-day white + 7-day peach schedule (total 28 days) but do not explicitly define what the numeral “28” in the product name refers to.
Vienva 28 is a brand-name product.
The provided excerpts do not explicitly state that “Vienva 28” is a brand-name product (the label text provided uses “Vienva (levonorgestrel and ethinyl estradiol tablets, USP)”).
Contradictions
Important Omissions
Safety-related information on urgent evaluation/disposition is not accurately presented for symptom triage (the label excerpts provided discuss discontinuation/evaluation rather than “seek urgent medical care” instructions). This missing alignment is material for the specific claims about urgency guidance.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Two specific symptom/urgency triage statements (“seek urgent medical care” for blood clot signs and for severe headache) are not supported by the provided label excerpts. The rest of the response is largely consistent with supported adverse reaction information and dosing instructions.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Safety triage language (“seek urgent medical care”) and specific symptom list are not label-supported in the provided prescribing information excerpts.
Suggested Improvement
Replace urgent-care triage phrasing with label-supported instructions (e.g., label-supported guidance about discontinuation/evaluation for severe or migraine-like headaches and thromboembolic/vascular warnings), without adding symptom-specific “seek urgent medical care” directives that are not present in the provided sections.